8 pending office actions • 3 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (50%) |
| §112 only | 1 (12%) |
| Double-patenting only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANDSMAN, ROBERT S | 1 | 81.4% | +13.1% |
| VAN DRUFF, SYDNEY | 1 | 56.4% | +29.5% |
| TSAY, MARSHA M | 1 | 45.7% | +52.4% |
| TAYLOR, LIA ELAN | 1 | 64.1% | +28.6% |
| CORNET, JEAN P | 1 | 42.0% | +47.6% |
| MCCOLLUM, ANDREA K | 1 | 60.9% | +32.1% |
| ISMAIL, REHANA | 1 | 78.3% | +31.6% |
| MOORE, SUSANNA | 1 | 68.0% | +31.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681162 | Method To Purify An Antibody Composition Using Cation Exchange Chromatography | LANDSMAN, ROBERT S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17766823 | STABLE FORMULATION OF INTEGRIN ANTIBODY | MCCOLLUM, ANDREA K | 18d overdue |
| 18275255 | CELL CULTURE METHODS | TSAY, MARSHA M | 8d |
| 17058390 | PRODRUGS OF FULVESTRANT | MOORE, SUSANNA | 27d |
| 18681162 | Method To Purify An Antibody Composition Using Cation Exchange Chromatography | LANDSMAN, ROBERT S | — |
| 18291909 | Method To Control High Molecular Weight Aggregates In An Antibody Composition | VAN DRUFF, SYDNEY | — |
| 18273142 | FREEZE DRIED ANTIBODY FORMULATIONS AND METHODS THEREOF | TAYLOR, LIA ELAN | — |
| 17779015 | PRODRUGS OF FULVESTRANT | CORNET, JEAN P | — |
| 17623556 | CHEMICAL INHIBITORS OF ID PROTEINS FOR THE TREATMENT OF CANCER AND OTHER DISEASES | ISMAIL, REHANA | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Dr. Reddy's | 5 |
| KASHIV BIOSCIENCES, LLC | 2 |
| Heidelberg University | 1 |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| 1641 | 1 |
| 1628 | 1 |
| 1674 | 1 |
| 1625 | 1 |
| 1624 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18681162 | Method To Purify An Antibody Composition Using Cation Exchange Chromatography | DR. REDDY'S LABORATORIES LIMITED | LANDSMAN, ROBERT S | DP | Non-Final OA | — | Pending | Feb 05, 2024 | |
| 18291909 | Method To Control High Molecular Weight Aggregates In An Antibody Composition | DR. REDDY'S LABORATORIES LIMITED | VAN DRUFF, SYDNEY | §103 | Non-Final OA | — | Pending | Jan 24, 2024 | |
| 18275255 | CELL CULTURE METHODS | DR. REDDY'S LABORATORIES LIMITED | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | 8d | Pending | Aug 01, 2023 |
| 18273142 | FREEZE DRIED ANTIBODY FORMULATIONS AND METHODS THEREOF | DR. REDDY'S LABORATORIES LIMITED | TAYLOR, LIA ELAN | 1641 | DP | Non-Final OA | — | Pending | Jul 19, 2023 |
| 17779015 | PRODRUGS OF FULVESTRANT | Kashiv Biosciences, LLC | CORNET, JEAN P | 1628 | DPOther | Non-Final OA | — | Pending | May 23, 2022 |
| 17766823 | STABLE FORMULATION OF INTEGRIN ANTIBODY | DR. REDDY'S LABORATORIES LIMITED | MCCOLLUM, ANDREA K | 1674 | §112 | Final Rejection | 18d overdue | Pending | Apr 06, 2022 |
| 17623556 | CHEMICAL INHIBITORS OF ID PROTEINS FOR THE TREATMENT OF CANCER AND OTHER DISEASES | UNIVERSITAT HEIDELBERG | ISMAIL, REHANA | 1625 | §103 | Non-Final OA | — | Pending | Dec 28, 2021 |
| 17058390 | PRODRUGS OF FULVESTRANT | Kashiv Biosciences, LLC | MOORE, SUSANNA | 1624 | §103 | Non-Final OA | 27d | Pending | Nov 24, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial